Table 2.
Analyte | Active morphea (n = 67), n (%) |
Inactive morphea (n = 34), n (%) |
||
---|---|---|---|---|
Increased frequency in active disease | ||||
CXCL9 | 25 | (37) | 3 | (9) |
IL-12 | 22 | (33) | 5 | (15) |
MIP-lα | 18 | (27) | 4 | (12) |
HGF | 17 | (25) | 1 | (3) |
IL-4 | 14 | (21) | 2 | (6) |
TNF-α | 10 | (15) | 0 | (0) |
Similar frequency in active and inactive disease | ||||
CXCL10 | 32 | (48) | 12 | (35) |
IL-2R | 26 | (39) | 8 | (24) |
IL-13 | 14 | (21) | 5 | (15) |
MIP-1β | 14 | (21) | 5 | (15) |
MCP-1 | 14 | (21) | 9 | (26) |
Abbreviation: TNF, tumor necrosis factor.